Device
E-Nose
E-Nose is a medical device with 5 clinical trials. Currently 1 active trials ongoing.
Total Trials
5
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Active Trials
1(20%)
Phase Distribution
Ph not_applicable
4
80%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
5
all time
Status Distribution
Active(1)
Other(4)
Detailed Status
unknown4
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
1
Success Rate
N/A
Most Advanced
N/A
Trials by Phase
N/A4 (100.0%)
Trials by Status
unknown480%
active_not_recruiting120%
Recent Activity
1 active trials
Showing 5 of 5
active_not_recruiting
Phenotyping and Classifying Asthma Exacerbations
NCT05304039
unknownnot_applicable
Biomarkers Of Lung InVolvement In ASMD
NCT05914727
unknownnot_applicable
E-Nose: Diagnostic Tool for Pleural TB
NCT02765087
unknownnot_applicable
E-nose Utility in the Diagnosis of Bacterial Infection in COPD
NCT01976117
unknownnot_applicable
Diagnostic Trial to Validate the Use of the E-Nose in Pulmonary TB
NCT02768909
Clinical Trials (5)
Showing 5 of 5 trials
NCT05304039
Phenotyping and Classifying Asthma Exacerbations
NCT05914727Not Applicable
Biomarkers Of Lung InVolvement In ASMD
NCT02765087Not Applicable
E-Nose: Diagnostic Tool for Pleural TB
NCT01976117Not Applicable
E-nose Utility in the Diagnosis of Bacterial Infection in COPD
NCT02768909Not Applicable
Diagnostic Trial to Validate the Use of the E-Nose in Pulmonary TB
All 5 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 5